BIOGEN INC. Debt Instrument, Face Amount
BIOGEN INC. (BIIB) had Debt Instrument, Face Amount of $6.00 billion as of 2015-12-31, per its 10-K filed 2016-02-03.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2025-02-12
- 2015-12-31: Debt Instrument, Face Amount $6.00B.
- 2015-09-30: Debt Instrument, Face Amount $6.00B.
- 2015-09-15: Debt Instrument, Face Amount $1.00B.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2015-12-31 | $6.00B 10-K · filed 2016-02-03 |
| 2015-09-30 | $6.00B 10-Q · filed 2015-10-21 |
| 2015-09-15 | $1.00B 10-K · filed 2025-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |